CoChat

Dexamethasone inhibits the release of TSH from the rat anterior pituitary gland in vitro by mechanisms dependent on de novo protein synthesis and lipocortin 1

Taylor, A D, Flower, R J, Buckingham, J C · 1995 · Journal of Endocrinology
Cited by 54

The DOI matches its Crossref record.

Abstract

Glucocorticoids have been shown repeatedly to inhibit the secretion of TSH in experimental animals and in man but their site and mode of action are unknown. In the present study, we have used an in vitro model to examine the effects of dexamethasone on the resting and pharmacologically evoked secretion of TSH by the rat anterior pituitary gland, and to show how they are influenced by inhibitors of RNA/protein synthesis. In addition, we have investigated the potential role of lipocortin 1 (LC1), a protein shown previously to contribute to glucocorticoid action in several systems, as a mediator of the glucocorticoid-induced suppression of TSH release in our in vitro preparation. The significant (P<0·01) increases in the release of immunoreactive (ir)TSH from rat anterior pituitary tissue initiated by submaximal concentrations of TRH (10 nmol/l), vasoactive intestinal polypeptide (VIP, 10 nmol/l) or the adenyl cyclase activator, forskolin (100 μmol/l) were reduced significantly (P<0·05) by preincubation of the tissue with dexamethasone (0·1 μmol/l). In contrast, irTSH secretion evoked by a submaximal concentration of the L-Ca 2+ channel opener BAY K8644 (10 μmol/l) was unaffected by the steroid, although readily antagonised (P<0·01) by nifedipine (1–100 μmol/l). Inclusion of actinomycin D (1·78 μmol/l) or cycloheximide (0·8 μmol/l), inhibitors of RNA and protein synthesis respectively, in the medium effectively abrogated the inhibitory effects of dexamethasone (0·1 μmol/l) on the secretory responses to TRH (10 nmol/l), VIP (10 nmol/l) and forskolin (100 μmol/l). LC1 was readily detectable by Western blotting in protein extracts of freshly excised anterior pituitary tissue. A small proportion of the protein was found to be attached to the outer surface of the cells where it was retained by a Ca 2+-dependent mechanism. Exposure of the tissue to dexamethasone (0·1 μmol/l) caused a pronounced increase in the amount of cellular LC1 attached to the outer surface of the cells and a concomitant decrease in the intracellular LC1 pool. Progesterone (0·1 μmol/l) and aldosterone (0·1 μmol/l) were also weakly active in this regard, but thyroxine and tri-iodothyronine (0·1 μmol/l) were not. Addition of an N-terminal LC1 fragment, LC1(1–188) (0·05–0·53 pmol/l) to the incubation medium reduced significantly (P<0·01) the increases in irTSH release induced by TRH (10 nmol/l), VIP (10 nmol/l) and forskolin (100 μmol/l), but failed to influence (P<0·05) those initiated by BAY K8644 (10 μmol/l). Furthermore, the inhibitory actions of dexamethasone (0·1 μmol/l) on the release of irTSH provoked by TRH (10 nmol/l), VIP (10 nmol/l) and forskolin (100 μmol/l) were substantially reversed (P<0·01) by a specific monoclonal anti-LC1 antibody, while an isotype-matched control antibody was without effect. The results show clearly that dexamethasone, a semisynthetic glucocorticoid, acts at the pituitary level to inhibit the neurochemically evoked release of irTSH. They also provide novel evidence that the inhibitory actions of the steroid are dependent upon de novo RNA/protein synthesis and that they involve an LC1 dependent mechanism. Journal of Endocrinology (1995) 147, 533–544

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1677/joe.0.1470533

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Taylor, A. D., Flower, R. J., & Buckingham, J. C.
Venue
Journal of Endocrinology
Published
1995-12
Volume
147
Issue
3
Pages
533-544
ISSN
  • 0022-0795 (ISSN-L)
  • 1479-6805
OpenAlex
W2148321746
Cited by
54
References
0
FWCI
1.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.